Company
Nanjing Leads Biolabs Co.,Ltd
Nanjing Leads Biolabs Co.,Ltd has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| LBL-034 for Injection | Phase 1/2 | Relapsed/Refractory Multiple Myeloma |
Latest
No recent events.
Follow Nanjing Leads Biolabs Co.,Ltd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.